The US Food and Drug Administration has given the green light for Arexvy to be prescribed to patients between the ages of 50 and 59.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.